Doctors in the UK have successfully developed a simple, non-invasive test that could significantly aid in ruling out womb cancer in women experiencing bleeding after menopause.
This innovative approach holds the potential to revolutionize care for thousands of women annually, sparing them from the need for uncomfortable and invasive diagnostic procedures, while also offering cost efficiencies for healthcare systems.